Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons

European Journal of Pharmacology

Volumn 574, Issue 1, 2007, Pages 8-14

  Dayanithi, Govindan ^a   Desmadryl, Gilles ^a   Travo, Cécile ^a   Chabbert, Christian ^a   Sans, Alain ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Ca2+ i; AMPA kainate receptors; Electrophysiology; Inner ear; Sensory neurons; Trimetazidine

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CADMIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; FURA 2; GLUTAMATE RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NICKEL; POTASSIUM ION; TRIMETAZIDINE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DEPOLARIZATION; DOSE RESPONSE; DRUG EFFECT; GANGLION; IC 50; MICROFLUOROMETRY; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; VESTIBULAR NERVE;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CATIONS, DIVALENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FLUORESCENT DYES; FURA-2; GANGLIA, SENSORY; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; TRIMETAZIDINE; VASODILATOR AGENTS; VESTIBULE, LABYRINTH;

EID: 34948901933     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.003     Document Type: Article

References (36)

1. Aubert A., Bernard C., Clauser P., Harpey C., and Vaudry H. The antiischemic drug, trimetazidine, prevents the deleterious effects of oxygene free radicals on the inner ear. Drugs of Today 26 (1990) 33-41
2. Bledsoe S.C., Bobbin R.P., and Puel J.L. Neurotransmission in the inner ear. In: Jahn A.F., and Santos-Sacchi J.R. (Eds). Physiology of Hearing (1988), Raven Press, New York 385-406
3. Bonsacquet J., Brugeaud A., Compan V., Desmadryl G., and Chabbert C. AMPA type glutamate receptor mediates neurotransmission at turtle vestibular calyx synapse. J. Physiol. 576 (2006) 63-71
4. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
5. Coyas A. The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial. Ann. Oto-laryngol. Chir. Cervico-fac. 107 Suppl 1 (1990) 82-87
6. d'Aldin C.G., Ruel J., Assie R., Pujol R., and Puel J.L. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea. Int. J. Dev. Neurosci. 15 (1997) 619-629
7. 2+ increase in isolated rat supraoptic cells. J. Physiol. 490 (1996) 713-727
8. 2+ regulation in rat motoneurons during development. Cell Calcium 39 (2006) 237-246
9. Delbarre B., Delbarre G., and Calinon F. Action of trimetazidine on retina of gerbils after ischemia reperfusion insult: determination of.OH, amino acids, and electroretinogram. Ann. N. Y. Acad. Sci. 738 (1994) 334-340
10. Dememes D., Lleixa A., and Dechesne C.J. Cellular and subcellular localization of AMPA-selective glutamate receptors in the mammalian peripheral vestibular system. Brain Res. 671 (1995) 83-94
11. Devau G., Lehouelleur J., and Sans A. Glutamate receptors on type I vestibular hair cells of guinea-pig. Eur. J. Neurosci. 5 (1993) 1210-1217
12. Dutrait N., Culcasi M., Cazevieille C., Pietri S., Tordo P., Bonne C., and Muller A. Calcium-dependent free radical generation in cultured retinal neurons injured by kainate. Neurosci. Lett. 198 (1995) 13-16
13. Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol. Rev. 73 (1993) 309-373
14. Fantini E., Demaison L., Sentex E., Grynberg A., and Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J. Mol. Cell Cardiol. 26 (1994) 949-958
15. Gil-Loyzaga P., Hernandez E., Carricondo F., Simon F., and Poch-Broto J. Trimetazidine prevents cochlear lesions induced by intraperitoneal and perilymphatic administration of kainic acid. Brain Res. 826 (1999) 95-103
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
17. Guth P.S., Aubert A., Ricci A.J., and Norris C.H. Differential modulation of spontaneous and evoked neurotransmitter release from hair cells: some novel hypotheses. Hear. Res. 56 (1991) 69-78
18. Jamen F., Alonso G., Shibuya I., Widmer H., Vacher C.M., Calas A., Bockaert J., Brabet P., and Dayanithi G. Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I-receptor deficient mice. J. Neuroendocrinol. 15 (2003) 871-881
19. Juiz J.M., Rueda J., Merchan J.A., and Sala M.L. The effects of kainic acid on the cochlear ganglion of the rat. Hear. Res. 40 (1989) 65-74
20. Kantor P.F., Lucien A., Kozak R., and Lopaschuk G.D. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 86 (2000) 580-588
21. 2+ handling in isoprenaline-mediated myocardial injury of rats. Exp. Physiol. 91 (2006) 591-601
22. Mohand-Said S., Jacquet A., Lucien A., Espinasse-Berrod M.A., Frasson Correa De Silva M., and Sahel J. Protective effect of trimetazidine in a model of ischemia-reperfusion in the rat retina. Ophthalmic Res. 34 (2002) 300-305
23. Niedzielski A.S., and Wenthold R.J. Expression of AMPA, kainate, and NMDA receptor subunits in cochlear and vestibular ganglia. J. Neurosci. 15 (1995) 2338-2353
24. Ozden S., Kildaci B., Muftuoglu S., Cakar N., and Yildirim C. Effect of trimetazidine on retinal ischemia/reperfusion injury in rats. Ophthalmologica 215 (2001) 309-317
25. Payet O., D'Aldin C., Maurin L., Bonne C., and Muller A. Anti-excitotoxic activity of trimetazidine in the retina. J. Ocular Pharmacol. Ther. 20 (2004) 85-92
26. Puel J.L. Chemical synaptic transmission in the cochlea. Prog. Neurobiol. 47 (1995) 449-476
27. Puel J.L., Pujol R., Tribillac F., Ladrech S., and Eybalin M. Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity. J. Comp. Neurol. 341 (1994) 241-256
28. Puel J.L., Ruel J., Guitton M., Wang J., and Pujol R. The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol. Neuro-otol. 7 (2002) 49-54
29. Rabejac D., Devau G., and Raymond J. AMPA receptors in cultured vestibular ganglion neurons: detection and activation. Eur. J. Neurosci. 9 (1997) 221-228
30. 2+ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc. Drugs Ther. 1 (1988) 677-686
31. Ruel J., Chen C., Pujol R., Bobbin R.P., and Puel J.L. AMPA-preferring glutamate receptors in cochlear physiology of adult guinea-pig. J. Physiol. 518 (1999) 667-680
32. Ruel J., Bobbin R.P., Vidal D., Pujol R., and Puel J.L. The selective AMPA receptor antagonist GYKI 53784 blocks action potential generation and excitotoxicity in the guinea pig cochlea. Neuropharmacology 39 (2000) 1959-1973
33. Sentex E., Helies-Toussaint C., Rousseau D., Lucien A., Ferrary E., and Grynberg A. Influence of trimetazidine on the synthesis of complex lipids in the heart and other target organs. Fundam. Clin. Pharmacol. 15 (2001) 255-264
34. Szwed H. Clinical benefits of trimetazidine in patients with recurrent angina. Coron. Artery Dis. 15 Suppl 1 (2004) S17-S21
35. Tabbi-Anneni I., Helies-Toussaint C., Morin D., Bescond-Jacquet A., Lucien A., and Grynberg A. Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover?. J. Pharmacol. Exp. Ther. 304 (2003) 1003-1009
36. Viero C., Mechaly I., Aptel H., Puech S., Valmier J., Bancel F., and Dayanithi G. Rapid inhibition of Ca(2+) influx by neurosteroids in murine embryonic sensory neurones. Cell Calcium 40 (2006) 383-391